Oxytocin formulations ban to come into effect from July 1

Image
Press Trust of India New Delhi
Last Updated : Jun 27 2018 | 2:05 PM IST

From July 1, no private manufacturer will be allowed to manufacture Oxytocin for domestic use.

Oxytocin is a naturally-occurring hormone that causes uterine contractions during labour and helps new mothers lactate.

But its misuse is widespread in the dairy industry where livestock are injected with oxytocin to make them release milk at a time convenient to farmers. The hormone is also used to increase the size of vegetables such as pumpkins, watermelons, brinjals, gourds and cucumbers.

The Ministry of Health has restricted the manufacture of Oxytocin formulations for domestic use to public sector only. Now only Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL), a public sector company, would be manufacturing this drug for domestic use from that date.

The government has also banned the import of oxytocin and its formulations, besides bringing in some more regulations on the manufacture and sale of the controversial hormone.

"Oxytocin formulations meant for domestic consumption will be supplied by the manufacturer, i.e. KAPL, to registered hospitals and clinics in public and private sector directly. Oxytocin in any form or name will not be allowed to be sold through retail chemist," a health ministry statement said.

The ministry has advised all registered hospitals and clinics in public and private sector in the country to contact KAPL and place their orders with the company as the drug will not be available with retail chemists or any other manufacturer.

"The move is part of an effort to check the misuse of oxytocin by dairy operators and some farmers," a senior ministry official said.

The Himachal Pradesh High Court had in its judgment in 2016 observed that large-scale clandestine manufacture and sale of oxytocin was leading to its grave misuse, which was harmful to animals and humans.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 27 2018 | 2:05 PM IST

Next Story